Oregon 2024 Regular Session Status: In Committee

HB 4028 — Relating to health care.

Last action — In committee upon adjournment.

Track this bill free

No card. One bill, free forever — alerts when it moves.

  1. ✓
    Introduced
  2. 2
    In Committee
  3. 3
    Passed House
  4. 4
    Passed Senate
  5. 5
    To Executive
  6. 6
    Enacted

This bill died with 2024 Regular Session. It reached “In Committee” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.

This bill is no longer active — its legislative session has ended, so there is no live prognosis. It would have to be reintroduced in the current session to move again.

Summary

<b>Digest: The Act prohibits drug makers from taking actions that make it hard for a drug store to get certain drugs on behalf of certain types of health care providers or deliver the drugs to the providers. The Act also prohibits drug makers from taking actions that make it hard for drug stores to deliver the drugs to the providers. (Flesch Readability Score: 63.5).</b> [<i>Digest: The Act requires the OHA to study the problems in getting health care in this state and to send a report of its findings to the legislature. The section is repealed on January 2, 2026. (Flesch Readability Score: 60.9).</i>] [<i>Requires the Oregon Health Authority to study access to health care in this state. Directs the authority to submit its findings to the interim committees of the Legislative Assembly related to health not later than September 15, 2025.</i>] <b>Prohibits drug manufacturers from interfering directly or indirectly with a pharmacy or drug outlet acquiring 340B drugs for or delivering 340B drugs to certain health care providers.</b>

Bill Text

We don't have the full text on file for this bill yet.

Read HB 4028 on the official Oregon source →

Action History

  1. In committee upon adjournment.

  2. Read.

  3. Motion to rerefer to Rules carried. Rereferred.

  4. Second reading.

  5. Subsequent referral to Ways and Means rescinded by order of the Speaker.

  6. Recommendation: Do pass with amendments, be printed A-Engrossed, and subsequent referral to Ways and Means be rescinded.

  7. Work Session held.

  8. Public Hearing held.

  9. Public Hearing held.

  10. Referred to Rules with subsequent referral to Ways and Means.

  11. First reading. Referred to Speaker's desk.

Sponsorship breakdown

Export CSV (upgrade) →

0 sponsors · 0 co-sponsors · 90 not signed on · 3 voted No

Sponsors (0)

None.

Co-sponsors (0)

None.

Not signed on (90)

90 members have not signed on to this bill.

Show all 90 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Votes

Subjects

healthcare health-insurance
Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

What does HB 4028 do?
<b>Digest: The Act prohibits drug makers from taking actions that make it hard for a drug store to get certain drugs on behalf of certain types of health care providers or deliver the drugs to the providers. The Act also prohibits drug makers from taking actions that make it hard for drug stores to deliver the drugs to the providers. (Flesch Readability Score: 63.5).</b> [<i>Digest: The Act requires the OHA to study the problems in getting health care in this state and to send a report of its findings to the legislature. The section is repealed on January 2, 2026. (Flesch Readability Score: 60.9).</i>] [<i>Requires the Oregon Health Authority to study access to health care in this state. Directs the authority to submit its findings to the interim committees of the Legislative Assembly related to health not later than September 15, 2025.</i>] <b>Prohibits drug manufacturers from interfering directly or indirectly with a pharmacy or drug outlet acquiring 340B drugs for or delivering 340B drugs to certain health care providers.</b>
What is the current status of HB 4028?
This bill died with 2024 Regular Session. It reached “In Committee” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.
Where can I track HB 4028?
Track HB 4028 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on HB 4028

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Find my representatives → Run a campaign

Stay ahead of HB 4028

Last checked for changes 3 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →